ATE390921T1 - Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung - Google Patents

Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung

Info

Publication number: ATE390921T1
Authority: AT; Austria
Prior art keywords: platinum; combination; containing anticancer; anticancer agents; demethylcantharidine
Prior art date: 2001-05-31

Application number

AT01951327T

Other languages

English (en)

Inventor

Steve C F Au-Yeung

Kenneth K W To

Yee-Ping Ho

Original Assignee

Univ Hong Kong Chinese

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-31

Filing date

2001-05-31

Publication date

2008-04-15

2001-05-31 Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE390921T1 publication Critical patent/ATE390921T1/de

Links

239000002246 antineoplastic agent Substances 0.000 title abstract 3
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
229960004562 carboplatin Drugs 0.000 abstract 2
190000008236 carboplatin Chemical compound 0.000 abstract 2
229960004316 cisplatin Drugs 0.000 abstract 2
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 2
229960001756 oxaliplatin Drugs 0.000 abstract 2
DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 abstract 2
229910052697 platinum Inorganic materials 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT01951327T 2001-05-31 2001-05-31 Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung ATE390921T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/CN2001/000885 WO2002096413A1 (en)	2001-05-31	2001-05-31	Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof

Publications (1)

Publication Number	Publication Date
ATE390921T1 true ATE390921T1 (de)	2008-04-15

Family

ID=4574808

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01951327T ATE390921T1 (de)	2001-05-31	2001-05-31	Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung

Country Status (7)

Country	Link
US (1)	US20040152766A1 (de)
EP (1)	EP1390027B1 (de)
JP (1)	JP2004532260A (de)
CN (1)	CN1237065C (de)
AT (1)	ATE390921T1 (de)
DE (1)	DE60133491D1 (de)
WO (1)	WO2002096413A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60319439T2 (de) *	2003-03-28	2008-06-19	Meiji Dairies Corp.	Verfahren zur herstellung von langkettigen cyclohexenonalkolen
CN1680384A (zh) *	2004-04-08	2005-10-12	香港中文大学	去甲基斑蟊素铂配合物及其用途
JP6810693B2 (ja) *	2014-12-17	2021-01-06	ヴェリカファーマシューティカルズ, インコーポレイテッドVerrica Pharmaceuticals, Inc.	カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成
EP3297440A4 (de)	2015-06-19	2019-04-10	Syn-Nat Products Enterprise LLC	Zusammensetzung mit carboplatin und verwendung
US11147790B2 (en)	2017-06-06	2021-10-19	Verrica Pharmaceuticals Inc.	Treatment of cutaneous disorders
CA3253199A1 (en)	2017-06-15	2025-10-30	Verrica Pharmaceuticals Inc.	Devices and methods for the treatment of body surface disorders
USD900312S1 (en)	2017-06-15	2020-10-27	Verrica Pharmaceuticals, Inc.	Applicator
AU2018346414B2 (en)	2017-10-04	2023-07-06	Verrica Pharmaceuticals, Inc.	Synthesis of cantharidin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1068002C (zh) *	1997-04-30	2001-07-04	中国科学院大连化学物理研究所	铂抗癌药物及合成
AUPP466598A0 (en) *	1998-07-14	1998-08-06	University Of Newcastle Research Associates Limited, The	Product and process

2001
- 2001-05-31 AT AT01951327T patent/ATE390921T1/de not_active IP Right Cessation
- 2001-05-31 EP EP01951327A patent/EP1390027B1/de not_active Expired - Lifetime
- 2001-05-31 CN CNB018231403A patent/CN1237065C/zh not_active Expired - Fee Related
- 2001-05-31 US US10/479,441 patent/US20040152766A1/en not_active Abandoned
- 2001-05-31 JP JP2002592923A patent/JP2004532260A/ja active Pending
- 2001-05-31 WO PCT/CN2001/000885 patent/WO2002096413A1/en not_active Ceased
- 2001-05-31 DE DE60133491T patent/DE60133491D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60133491D1 (de)	2008-05-15
WO2002096413A1 (en)	2002-12-05
HK1064955A1 (en)	2005-02-08
EP1390027A1 (de)	2004-02-25
US20040152766A1 (en)	2004-08-05
CN1499966A (zh)	2004-05-26
JP2004532260A (ja)	2004-10-21
EP1390027B1 (de)	2008-04-02
EP1390027A4 (de)	2004-06-30
CN1237065C (zh)	2006-01-18

Similar Documents

Publication	Publication Date	Title
TW200635923A (en)	2006-10-16	Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
ATE350409T1 (de)	2007-01-15	Ampholytisches copolymer und dessen verwendung
ATE538103T1 (de)	2012-01-15	Chinazolinonverbindungen als antikrebsmittel
MX2007002189A (es)	2008-01-11	Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
PL1742644T3 (pl)	2012-05-31	Kompozycja terapeutyczna zawierająca co najmniej jedną pochodną pirolobenzodiazepiny i fludarabiny
DE60001974D1 (de)	2003-05-08	Derivate von flavonen, xanthonen und kumarinen
WO2006044362A3 (en)	2006-12-07	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
TR200100054T2 (tr)	2001-06-21	Paroksetin metansülfonat
TW200624431A (en)	2006-07-16	Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
WO2002102306A8 (en)	2004-05-21	Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
ATE291424T1 (de)	2005-04-15	Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
PT1121127E (pt)	2005-03-31	Composicoes farmaceuticas orais contendo buprenorfina
DE60209721D1 (de)	2006-05-04	Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
IL157540A0 (en)	2004-03-28	N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
ATE240303T1 (de)	2003-05-15	1,2,4-triazol-3-thion verbindungen
TW200531688A (en)	2005-10-01	Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
ATE499372T1 (de)	2011-03-15	Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
DE60133491D1 (de)	2008-05-15	Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung
ATE554753T1 (de)	2012-05-15	2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
TNSN07203A1 (en)	2008-11-21	Pharmaceutical compositions for the treatment of cellulite
EP1558282A4 (de)	2006-04-19	Zusammensetzungen gegen krebs und infektionskrankheiten und anwendungsverfahren dafür
ATE390124T1 (de)	2008-04-15	Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
HUP0203153A2 (hu)	2003-01-28	Kombinációs kemoterápia
DE602005011031D1 (en)	2008-12-24	Phosphoindole als hiv-inhibitoren
IL147890A0 (en)	2002-08-14	Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives

Legal Events

Date	Code	Title	Description
2008-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties